Search

Filters

Use filters to refine the search results.

Now showing items 1-10 of 10

Providing an address for delivery of nanoencapsulated TB drugs

Lemmer, Yolandy (2010-06)
Future of aptamers in medicine

Khati, M (BMJ Publishing Group, 2010-06)
Aptamer and nanotechnology- based approaches for active targeted delivery of anti-tuberculosis drugs

Ramalapa, B (2012-10)
An overview of the CSIR Health Research Impact Area

Gardiner, D (2012-10)
Binding kinetics of aptamers to gp120 derived from HIV-1 subtype C

Millroy, L; London, G; Veale, R; Weinberg, M; Khati, M (Conference Poster, 2011-02)
UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C

Mufhandu, Hazel T; Gray, ES; Madiga, MC; Tumba, N; Alexandre, Kabamba B; Khoza, T; Wibmer, CK; Moore, PL; Morris, L; Khati, M (American Society for Microbiology, 2012-05)
Development of aptamer based HIV-1 entry inhibitor prophylactic drugs

London, G; Mufhandu, Hazel T; Sok, D; Morris, L; Burton, DR; Mayosi, B; Khati, M (OMICS Publishing Group, 2013-08)
Isolation and characterization of 20'-F-RNA aptamers against whole HIV-1 subtype C envelope pseudovirus

London, GM; Mayosi, BM; Khati, M (Elsevier, 2015-01)
Diagnosis of active TB using aptamers

Khati, M (OMICS Group conferences, 2013-08)
Towards HIV detection: Novel Poly(propylene imine) Dendrimer-Streptavidin platform for electrochemical DNA and gp120 aptamer biosensors

John, SV; Rotherham, LS; Khati, M; Mamba, BB; Arotiba, OA (Electrochemical Science Group, 2014-07)

Now showing items 1-10 of 10

Tel: + 27 12 841 2911
Email: callcentre@csir.co.za

Physical Address
Meiring Naudé Road
Brummeria
Pretoria
South Africa

Postal Address
PO Box 395
Pretoria 0001
South Africa